Dr. Migden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6655 Travis St
Houston, TX 77030Phone+1 713-500-8260Fax+1 713-524-3432- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 1998 - 2001- Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 1997 - 1998
University of Utah School of MedicineClass of 1997
Certifications & Licensure
TX State Medical License 2003 - 2025
OK State Medical License 2020 - 2021
AZ State Medical License 2000 - 2021
MN State Medical License 1999 - 2018
FL State Medical License 2001 - 2017
WI State Medical License 2003 - 2017- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FASDS) American Society for Dermatologic Surgery
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Spectral Diagnosis of Cutaneous Malignancy Start of enrollment: 2007 Apr 01
Publications & Presentations
PubMed
- Treatments on the horizon for locally advanced basal cell carcinoma.Michael R Migden, Munir H Idriss, Carolyn M Stull> ;Cancer Letters. 2024 Mar 21
- High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma.Danny Rischin, Brett G M Hughes, Nicole Basset-Séguin, Dirk Schadendorf, Samantha Bowyer, Sabiha Trabelsi Messai, Friedegund Meier, Thomas K Eigentler, Victoria Casado...> ;Journal for Immunotherapy of Cancer. 2024 Mar 11
- 2 citationsPhase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follo...Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Karl D Lewis, Nicole Basset-Seguin, Anne Lynn S Chang, Stéphane Dalle, Almudena F...> ;Journal of the American Academy of Dermatology. 2024 Feb 1
- Join now to see all
Journal Articles
- PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell CarcinomaJade Homsi, Michael R Migden, Nikhil I Khushalani, The New England Journal of Medicine
Lectures
- Primary analysis of Phase 2 results of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with locally advanced cutaneous squamous cell carcinoma (laCSCC).2019 ASCO Annual Meeting - 6/1/2019
- 42-month follow-up of sonidegib efficacy and safety in advanced basal cell carcinoma: Final analysis from BOLT.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Parting Advice on Non-Melanoma Skin Cancer ManagementJuly 22nd, 2019
Clinical Challenges: What’s Next for Cutaneous Squamous Cell Carcinoma?June 15th, 2019
First Treatment Approved for Common Form of Advanced Skin CancerOctober 1st, 2018- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Memorial Hermann - Texas Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
